22.01. à 24.01.2025 | Lugano, Zurich, Lausanne, Geneva, Bern, and Basel
This event will sweep across six major Swiss cities and feature input from leading neurology experts, such as Dr. Patricia Pozo-Rosich.
This event aims to explore the practical implications of clinical findings from the Atogepant studies. Topics of discussion will not only focus on patient management strategies and goal setting but will delve into the critical question of whether current care standards for patients are sufficient in migraine prophylaxis.